Controlled release budesonide minitablets

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8945615
APP PUB NO 20100209500A1
SERIAL NO

12372333

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises budesonide, a carrier, an extended release polymer, and an acid. The budesonide may be embedded in the extended release polymer to facilitate extended release of the budesonide upon administration.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MYLAN PHARMACEUTICALS INC781 CHESTNUT RIDGE ROAD MORGANTOWN WV 26505

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Boyong Morgantown, US 38 471
Murty, Mummini Aruna Morgantown, US 4 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00